![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
(51) | INT.CL. | C07D 477/20 | |
A61K 31/40 | |||
A61K 31/407 |
(11) | Patento numeris | 1332145 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 01934937.2 |
Europos patento paraiškos padavimo data | 2001-04-27 | |
(97) | Europos patento paraiškos paskelbimo data | 2003-08-06 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2007-11-14 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2001/013794 |
Data | 2001-04-27 |
(87) | Numeris | WO 2002/034750 |
Data | 2002-05-02 |
(30) | Numeris | Data | Šalis |
698808 | 2000-10-27 | US | |
PCT/US00/29869 | 2000-10-27 | WO |
(72) |
AL-DEHNEH, Anthony, US
HUNKE, William, A., US
ILLIG, Kathleen, J., US
KANIKE, Anand, US
PATEL, Hiren, US
REYNOLDS, Scott, D., US
TSINONTIDES, Stelios, C., US
|
(73) |
Merck & Co., Inc.,
126 East Lincoln Avenue, Rahway, New Jersey 07065-0907,
US
|
(54) | PROCESS FOR FORMULATION OF ANTIBIOTIC COMPOUNDS |
PROCESS FOR FORMULATION OF ANTIBIOTIC COMPOUNDS |